+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: not found

      Manejo y seguimiento radiológico del paciente post-COVID-19 Translated title: Radiological management and follow-up of post-COVID-19 patients

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          La mayor parte de los pacientes que superan la infección por SARS-CoV-2 no presentan complicaciones ni requieren un seguimiento específico, pero una proporción significativa (especialmente aquellos con formas clínicas moderadas/graves de la enfermedad) necesitan un seguimiento clínico-radiológico. Aunque apenas existen referencias o guías clínicas sobre el seguimiento a largo plazo de estos pacientes post-COVID-19, se están realizando pruebas radiológicas y constituyendo consultas monográficas de vigilancia en la mayor parte de los centros hospitalarios para atender sus necesidades. El propósito de este trabajo es compartir nuestra experiencia en el manejo del paciente post-COVID-19 en dos instituciones que han tenido una elevada incidencia de la COVID-19 y proponer unas recomendaciones generales de seguimiento desde una perspectiva clínica y radiológica.

          Translated abstract


          To describe the computed tomography (CT) findings in patients with COVID-19 in different phases of the disease and to evaluate the reliability and reproducibility of a visual radiologic score to estimate the lung inflammatory burden.


          We retrospectively reviewed chest CT studies from 182 patients with RT-PCR findings positive for SARS-CoV-2. Patients were classified according to the time elapsed from the onset of symptoms, as follows: early (0-4 days), intermediate/progressive (5-9 days), or advanced (≥10 days). We analyzed the frequency of each radiologic finding, as well as the predominant pattern, appearance, and distribution of lung involvement. A visual tomographic score (range, 0-25) was used to estimate the inflammatory in each lobe and in the entire lung volume.


          The predominant CT finding was the ground-glass pattern (n=110; 60.4%), the most common distribution was peripheral (n = 116; 66.7%), and the most prevalent appearance was typical (n=112; 61.5%). The halo sign was seen most frequently in the early phase, whereas ground-glass opacities, the crazy paving pattern, and subpleural bands were more common in the intermediate/progressive and advanced phases. The median severity score was 10 (IQR: 5-13), and the scores increased as the disease progressed. The interobserver agreement (kappa) was 0.89 for the visual score.


          The CT findings in patients with COVID-19 vary with the course of the infection. The proposed visual radiologic score is a simple, reproducible, and reliable tool for assessing lung involvement in COVID-19 pneumonia.

          Related collections

          Author and article information

          SERAM. Published by Elsevier España, S.L.U.
          27 February 2021
          27 February 2021
          [a ]Servicio de Radiodiagnóstico, Hospital Universitario Ramón y Cajal, Madrid, España
          [b ]Servicio de Radiodiagnóstico, Hospital Universitario La Paz, Madrid, España
          [c ]Servicio de Neumología, Hospital Universitario Ramón y Cajal, Madrid, España
          Author notes
          [* ]Autor para correspondencia.
          © 2021 SERAM. Published by Elsevier España, S.L.U. All rights reserved.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.



          Comment on this article